TYRA
Tyra Biosciences·NASDAQ
--
--(--)
--
--(--)
5.60 / 10
Netural
Analyst view is a single Buy (100%) with limited history and low win rate, while fund‑flow scores 7.5/10. Small, medium and large investors show net inflows, but overall and block trends are negative. Mixed sentiment warrants careful monitoring.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-20
InstitutionPiper Sandler
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for TYRA?
- TYRA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.60/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
